Better Buy: Vertex Pharmaceuticals vs. Galapagos
If you only looked at year-to-date performance, Galapagos (NASDAQ: GLPG) would be a slam-dunk pick over Vertex Pharmaceuticals (NASDAQ: VRTX). Galapagos is up more than 70% so far this year, while Vertex has achieved only a single-digit percentage gain.
But choosing a stock based on its recent performance isn't a smart move. It's much wiser to evaluate the underlying growth prospects for each stock before making a decision. With that in mind, here's how Vertex and Galapagos stack up against each other.
Image source: Getty Images.
Source Fool.com
